[EN] BCAT2 INHIBITORS<br/>[FR] INHIBITEURS DE BCAT2
申请人:[en]AGIOS PHARMACEUTICALS, INC.
公开号:WO2023086539A2
公开(公告)日:2023-05-19
The disclosure is directed to compounds, and pharmaceutically acceptable salts thereof, that inhibit branched-chain amino acid aminotransferase 2 (BCAT2), pharmaceutical compositions comprising those compounds, and methods of using those compounds for treating branched chain amino acid (BCAA)-catabolism-related diseases.